APPENDIX B
ICD-9 Codes for Health Outcomes of Interest
The International Classification of Diseases, Ninth Edition (ICD-9) is a system used by physicians and researchers around the world to group related disease entities and procedures for the reporting of statistical information. It is used for the purposes of classifying morbidity and mortality information for statistical purposes, indexing hospital records by disease and operations, reporting diagnosis by physicians, data storage and retrieval, reporting national morbidity and mortality data, and reporting and compiling health care data. Many of the studies reviewed by the committee use ICD-9 classifications. Table B-1 lists the codes for the various forms of cancer.
TABLE B-1 Surveillance, Epidemiology, and End Results (SEER) Program Site Groupings for ICD-9 National Center for Health Statistics (NCHS) Data
Site |
ICD-9 codes |
Cancer |
|
Buccal cavity and pharynx |
|
Lip |
140.0–140.9 |
Tongue |
141.0–141.9 |
Salivary glands |
142.0–142.9 |
Floor of mouth |
144.0–144.9 |
Gum and other mouth |
143.0–143.9, 145.0-145.6, 145.8-145.9 |
Nasopharynx |
147.0–147.9 |
Tonsil |
146.0–146.2 |
Oropharynx |
146.3–146.9 |
Hypopharynx |
148.0–148.9 |
Site |
ICD-9 codes |
Other buccal cavity and pharynx |
149.0–149.9 |
Digestive system |
|
Esophagus |
150.0–150.9 |
Stomach |
151.0–151.9 |
Small intestine |
152.0–152.9 |
Colon excluding rectum |
153.0–153.9, 159.0 |
Rectum and rectosigmoid |
154.0–154.1 |
Anus, anal canal, and anorectum |
154.2–154.3, 154.8 |
Liver and intrahepatic bile duct |
|
Liver |
155.0, 155.2 |
Intrahepatic bile duct |
155.1 |
Gallbladder |
156.0 |
Other biliary |
156.1–156.9 |
Pancreas |
157.0–157.9 |
Retroperitoneum |
158.0 |
Peritoneum, omentum, and mesentery |
158.8–158.9 |
Other digestive organs |
159.8–159.9 |
Respiratory system |
|
Nasal cavity, middle ear, and accessory sinuses |
160.0–160.9 |
Larynx |
161.0–161.9 |
Lung and bronchus |
162.2–162.9 |
Pleura |
163.0–163.9 |
Trachea, mediastinum, and other respiratory organs |
162.0, 164.2–165.9 |
Bones and joints |
170.0–170.9 |
Soft tissue (including heart) |
171.0–171.9, 164.1 |
Skin |
|
Melanomas—skin |
172.0–172.9 |
Other nonepithelial skin |
173.0–173.9 |
Breast |
174.0–174.9, 175.0 |
Female genital system |
|
Cervix |
180.0–180.9 |
Corpus |
182.0–182.1, 182.8 |
Uterus, NOS |
179.0 |
Ovary |
183.0 |
Vagina |
184.0 |
Vulva |
184.1–184.4 |
Other female genital organs |
181, 183.2–183.9, 184.8, 184.9 |
Male genital system |
|
Prostate |
185.0 |
Testis |
186.0–186.9 |
Penis |
187.1–187.4 |
Other male genital organs |
187.5–187.9 |
Urinary system |
|
Urinary bladder |
188.0–188.9 |
Kidney and renal pelvis |
189.0, 189.1 |
Ureter |
189.2 |
Other urinary organs |
189.3–189.4, 189.8–189.9 |
Site |
ICD-9 codes |
Eye and orbit |
190.0–190.9 |
Brain and other nervous system |
|
Brain |
191.0–191.9 |
Other nervous system |
192.0–192.3, 192.8–192.9 |
Endocrine system |
|
Thyroid |
193.0 |
Other endocrine (including thymus) |
164.0, 194.0–194.9 |
Lymphomas |
|
Hodgkin's disease |
201.0–201.9 |
Non-Hodgkin's lymphomas |
200.0–200.8, 202.0–202.2, 202.8–202.9 |
Multiple myeloma |
203.0, 203.2–203.8 |
Leukemias |
|
Lymphocytic |
|
Acute lymphocytic |
204.0 |
Chronic lymphocytic |
204.1 |
Other lymphocytic |
204.2–204.9 |
Granulocytic (myeloid) |
|
Acute myeloid |
205.0 |
Chronic myeloid |
205.1 |
Other myeloid |
205.2–205.9 |
Monocytic |
|
Acute monocytic |
206.0 |
Chronic monocytic |
206.1 |
Other monocytic |
206.2–206.9 |
Other |
|
Other acute |
207.0, 208.0 |
Other chronic |
207.1, 208.1 |
Aleukemic, subleukemic and NOS |
202.4, 203.1, 207.2, 207.8, 208.2–208.9 |
Ill-defined and unspecified sites |
159.1, 195.0–195.8, 196.0–196.9, 199.0–199.1, 202.3, 202.5–202.6 |
Note: NOS = not otherwise specified. Source: Ries LAG, Kosary CL, Hankey BF, Miller BA, Harras A, EdwardsBK (eds) 1997. SEER Cancer Statistics Review, 1973–1994, NationalCancer Institute. NIH Pub. No. 97 2789. Bethesda, MD. Table A-4. |